Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cellular and Molecular Life Sciences : CMLS|January 29, 2022
MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axisSrishti Srivastava, Hima Makala, Vikas Sharma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 31, 2025
CD24 as a Novel Radiopharmaceutical Target for Hepatocellular CarcinomaHima Makala, Julia Sheehan-Klenk, Woonghee Lee, et al.
Journal of Cellular Physiology|January 28, 2020
Ferroptotic agent-induced endoplasmic reticulum stress response plays a pivotal role in the autophagic process outcomeYoung-Sun Lee, Kalishwaralal Kalimuthu, Yong Seok Park, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
Tetraspanin-8 as a Tumor-Selective Immuno-PET Target in Hepatocellular CarcinomaJulia Sheehan-Klenk, Hima Makala, Joon-Yong Chung, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain AntibodyStanley Fayn, Swarnali Roy, Chino C Cabalteja, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 9, 2020
Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancerAshok K Dilly, Brendon D Honick, Robin Frederick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2026
A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver CancerDivya M Nambiar, Thomas J Esparza, Woonghee Lee, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for RadiotheranosticsPhilip Homan, Joon-Yong Chung, Woonghee Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PETStanley Fayn, Woonghee Lee, Falguni Basuli, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathwayJoon-Yong Chung, Hima Makala, Woonghee Lee, et al.
Pageof 2